BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao Y, Zhou J, Liu J, Wang Z, Chen M, Zhou S. Metagenome of Gut Microbiota of Children With Nonalcoholic Fatty Liver Disease. Front Pediatr 2019;7:518. [PMID: 31921729 DOI: 10.3389/fped.2019.00518] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Vander Wyst KB, Ortega-Santos CP, Toffoli SN, Lahti CE, Whisner CM. Diet, adiposity, and the gut microbiota from infancy to adolescence: A systematic review. Obes Rev 2021;22:e13175. [PMID: 33590719 DOI: 10.1111/obr.13175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
2 Tokuhara D. Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents. Front Nutr 2021;8:700058. [PMID: 34250000 DOI: 10.3389/fnut.2021.700058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Naseri M, Palizban F, Yadegar A, Khodarahmi M, Asadzadeh Aghdaei H, Houri H, Zahiri J. Investigation and characterization of human gut phageome in advanced liver cirrhosis of defined etiologies. Gut Pathog 2022;14:9. [PMID: 35168645 DOI: 10.1186/s13099-022-00482-4] [Reference Citation Analysis]
4 Crudele A, Panera N, Braghini MR, Balsano C, Alisi A. The pharmacological treatment of nonalcoholic fatty liver disease in children. Expert Rev Clin Pharmacol 2020;13:1219-27. [PMID: 32981386 DOI: 10.1080/17512433.2020.1829468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Song Q, Zhang X. The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC. Biomedicines 2022;10:524. [DOI: 10.3390/biomedicines10030524] [Reference Citation Analysis]
6 Riccio S, Melone R, Vitulano C, Guida P, Maddaluno I, Guarino S, Marzuillo P, Miraglia del Giudice E, Di Sessa A. Advances in pediatric non-alcoholic fatty liver disease: From genetics to lipidomics. World J Clin Pediatr 2022; 11(3): 221-238 [DOI: 10.5409/wjcp.v11.i3.221] [Reference Citation Analysis]
7 de Oliveira Neves VG, de Oliveira DT, Oliveira DC, Oliveira Perucci L, Dos Santos TAP, da Costa Fernandes I, de Sousa GG, Barboza NR, Guerra-Sá R. High-sugar diet intake, physical activity, and gut microbiota crosstalk: Implications for obesity in rats. Food Sci Nutr 2020;8:5683-95. [PMID: 33133570 DOI: 10.1002/fsn3.1842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Carrizales-Sánchez AK, García-Cayuela T, Hernández-Brenes C, Senés-Guerrero C. Gut microbiota associations with metabolic syndrome and relevance of its study in pediatric subjects. Gut Microbes 2021;13:1960135. [PMID: 34491882 DOI: 10.1080/19490976.2021.1960135] [Reference Citation Analysis]
9 Yu J, Zhang H, Chen L, Ruan Y, Chen Y, Liu Q. Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic Fatty Liver Disease. Front Cell Infect Microbiol 2021;11:698852. [PMID: 34568090 DOI: 10.3389/fcimb.2021.698852] [Reference Citation Analysis]
10 Li Z, Deng X, Luo J, Lei Y, Jin X, Zhu J, Lv G. Metabolomic Comparison of Patients With Colorectal Cancer at Different Anticancer Treatment Stages. Front Oncol 2022;11:574318. [DOI: 10.3389/fonc.2021.574318] [Reference Citation Analysis]
11 Nalbantoglu OU. Information Theoretic Metagenome Assembly Allows the Discovery of Disease Biomarkers in Human Microbiome. Entropy (Basel) 2021;23:187. [PMID: 33540903 DOI: 10.3390/e23020187] [Reference Citation Analysis]
12 Doulberis M, Papaefthymiou A, Srivastava DS, Exadaktylos AK, Katsinelos P, Kountouras J, Polyzos SA. Update on the association between non-alcoholic fatty liver disease and Helicobacter pylori infection. Int J Clin Pract 2021;75:e13737. [PMID: 32991019 DOI: 10.1111/ijcp.13737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]